RSV (Respiratory Syncytial Virus) Vaccine:

The US Food and Drug Administration approved Beyfortus (nirsevimab-alip) for the prevention of Respiratory Syncytial Virus (RSV) lower respiratory tract disease in neonates and infants born during or entering their first RSV season, and in children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season.

We will have this vaccines in office, Please call for appointment if interested or can be given at your child’s Well Care visit.

Our office is located at

7 Smith Avenue Suite 103
Greenville, RI 02828


Comments are closed.
Thursday, July 25, 2024
Copyright 2024 Smithfield Pediatrics